Loading
A phase 2 trial of F-MISO (JBS-003) run by Memorial Sloan Kettering Cancer Center, now recruiting.
A Study of Reduced Radiation Therapy With Chemotherapy in People With HPV-Positive Throat Cancer is a phase 2 interventional study registered as NCT06984861 by Memorial Sloan Kettering Cancer Center, with 74 participants planned, started 2025-05-13. Conditions recorded: Oropharyngeal Carcinoma. Interventions recorded: 18F-FMISO PET/CT Scan, Chemoradiation and Questionnaires.
Shares F-MISO (JBS-003), Juniper Biosciences, Oropharyngeal cancer (tonsil and base of tongue) and the tag pipeline.
Shares F-MISO (JBS-003), Juniper Biosciences and the tag pipeline.
Shares Oropharyngeal cancer (tonsil and base of tongue) and the tag pipeline.
Shares Oropharyngeal cancer (tonsil and base of tongue) and the tag pipeline.
Shares Oropharyngeal cancer (tonsil and base of tongue) and the tag pipeline.
Shares Oropharyngeal cancer (tonsil and base of tongue) and the tag pipeline.
Shares Oropharyngeal cancer (tonsil and base of tongue) and the tag pipeline.
Shares Oropharyngeal cancer (tonsil and base of tongue) and the tag pipeline.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/